MiMedx Group is committed to the commercialization of Biomaterials that improve surgical outcomes by solving an unmet or under-served clinical need.
CollaFix™ is a collagen-based resorbable biomaterial, designed to be strong while providing a scaffold for cellular ingrowth.
News and Events
-
MiMedx Exceeds First Quarter 2012 Revenue Goal April 4, 2012
-
MiMedx Announces 2011 Year End Results February 28, 2012



